Effects of angiotensin II receptor blocker on myocardial endothelial-to-mesenchymal transition in diabetic rats

International Journal of Cardiology

Volumn 162, Issue 2, 2013, Pages 92-99

  Tang, Ri Ning ^a   Lv, Lin Li ^a   Zhang, Jian Dong ^a   Dai, Hou Yong ^a   Li, Qing ^a   Zheng, Min ^a   Ni, Jie ^a   Ma, Kun Ling ^a   Liu, Bi Cheng ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Cardiac fibrosis; Diabetes; Endothelial to mesenchymal transition; Human aortic endothelial cells; Irbesartan; Rats

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CALVASCULIN; CD31 ANTIGEN; GLUCOSE; IRBESARTAN; HEMOGLOBIN A1C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CELL TRANSFORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; ELECTRON MICROSCOPY; ENDOTHELIAL MESENCHYMAL TRANSITION; ENDOTHELIUM CELL; GENE EXPRESSION; HEART MUSCLE; HEART MUSCLE FIBROSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSING ALVEOLITIS; GLUCOSE BLOOD LEVEL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN SYNTHESIS;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIPHENYL COMPOUNDS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DNA PRIMERS; ECHOCARDIOGRAPHY; ENDOTHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HEART; HUMANS; MALE; MICROSCOPY, CONFOCAL; RATS; RATS, INBRED SHR; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLES;

EID: 84870718120     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.06.052     Document Type: Article

References (36)

1. Center for Disease Control and Prevention (CDC) Self-reported heart disease and stroke among adults with and without diabetes-United States MMWR Morb Mortal Wkly Rep 2003 52 1999-2001 1065 1070
2. A. Cohen-Solal, F. Beauvais, and D. Logeart Heart failure and diabetes mellitus: epidemiology and management of an alarming association J Card Fail 14 2008 615 625
3. I.S. Thrainsdottir, T. Aspelund, and G. Thorgeirsson The association between glucose abnormalities and heart failure in the population based Reykjavík Study Diabetes Care 28 2005 612 616
4. M.J. Goumans, A.J. van Zonneveld, and P. ten Dijke Transforming growth factor β-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis? Trends Cardiovasc Med 18 2008 293 298
5. T.A. Wynn Cellular and molecular mechanisms of fibrosis J Pathol 214 2008 199 210
6. E.M. Zeisberg, O. Tarnavski, and M. Zeisberg Endothelial-to-mesenchymal transition contributes to cardiac fibrosis Nat Med 13 2007 952 961
7. E.M. Zeisberg, S.E. Potenta, H. Sugimoto, M. Zeisberg, and R. Kalluri Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition J Am Soc Nephrol 19 2008 2282 2287
8. L. Selek, M. Dhobb, B. van der Sanden, F. Berger, and D. Wion Existence of tumor-derived endothelial cells suggests an additional role for endothelial-to-mesenchymal transition in tumor progression Int J Cancer 2010 [Epub ahead of print]
9. S. Potenta, E. Zeisberg, and R. Kalluri The role of endothelial-to- mesenchymal transition in cancer progression Br J Cancer 99 2008 1375 1379
10. D. Huang, Y. Wang, C. Yang, Y. Liao, and K. Huang Angiotensin II promotes poly(ADP-ribosyl)ation of c-Jun/c-Fos in cardiac fibroblasts J Mol Cell Cardiol 46 2009 25 32
11. K.F. Croom, and G.L. Plosker Irbesartan a review of its use in hypertension and diabetic nephropathy Drugs 68 2008 1543 1569
12. K. Arishiro, M. Hoshiga, and N. Negoro Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits J Am Coll Cardiol 49 2007 1482 1489
13. K. Srinivasan, B. Viswanad, L. Asrat, C.L. Kaul, and P. Ramarao Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening Pharmacological Res 52 2005 313 320
14. D. Westermann, S. Rutschow, and S. Jager Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism Diabetes 56 2007 641 646
15. S.M. Haffner, A.S. Greenberg, W.M. Weston, H. Chen, K. Williams, and M.I. Freed Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus Circulation 106 2002 679 684
16. D.M. Ouwens, M. Diamant, and M. Fodor Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification Diabetologia 50 2007 1938 1948
17. S. Mohan, M. Hamuro, K. Koyoma, G.P. Sorescu, H. Jo, and M. Natarajan High glucose induced NF-kappaB DNA-binding activity in HAEC is maintained under low shear stress but inhibited under high shear stress: role of nitric oxide Atherosclerosis 171 2003 225 234
18. W.W. Batenburg, I.M. Garrelds, and C.C. Bernasconi Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries Circulation 109 2004 2296 2301
19. R. Tang, Q. Li, and L. Lv Angiotensin II mediates the high-glucose-induced endothelial-to-mesenchymal transition in human aortic endothelial cells Cardiovasc Diabetol 9 2010 31
20. K.E. Porter, and N.A. Turner Cardiac fibroblasts: at the heart of myocardial remodeling Pharmacol Ther 123 2009 255 278
21. V.P. Singh, K.M. Baker, and R. Kumar Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production Am J Physiol Heart Circ Physiol 294 2008 H1675 H1684
22. M. Iwano, D. Plieth, T.M. Danoff, C. Xue, H. Okada, and E.G. Neilson Evidence that fibroblasts derive from epithelium during tissue fibrosis J Clin Invest 110 2002 341 350
23. E. Arciniegas, M.G. Frid, I.S. Douglas, and K.R. Stenmark Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension Am J Physiol Lung Cell Mol Physiol 293 2007 L1 L8
24. B. Widyantoro, N. Emoto, and K. Nakayama Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition Circulation 121 2010 2407 2418
25. N.W. Shammas, D.A. Sica, and P.P. Toth A guide to the management of blood pressure in the diabetic hypertensive patient Am J Cardiovasc Drugs 9 2009 149 162
26. Roberto Negro Endothelial effects of antihypertensive treatment: focus on irbesartan Vasc Health Risk Manag 4 2008 89 101
27. J.M. Willemsen, J.W. Westerink, and G.M. Dallinga-Thie Angiotensin II type 1 receptor blockade improves hyperglycemia-induced endothelial dysfunction and reduces proinflammatory cytokine release from leukocytes J Cardiovasc Pharmacol 49 2007 6 12
28. E.B. Okon, T. Szado, I. Laher, B. McManus, and C. van Breemen Augmented contractile response of vascular smooth muscle in a diabetic mouse model J Vasc Res 40 2003 520 530
29. G.J. Lagaud, E. Masih-Khan, S. Kai, C. van Breemen, and G.P. Dube Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries J Vasc Res 38 2001 578 589
30. Y. Yu, K. Ohmori, and I. Kondo Correlation of functional and structural alterations of the coronary arterioles during development of type II diabetes mellitus in rats Cardiovasc Res 56 2002 303 311
31. C. Schaefer, T. Biermann, and M. Schroeder Early microvascular complications of prediabetes in mice with impaired glucose tolerance and dyslipidemia Acta Diabetol 47 2010 19 27
32. J.E. Tooke, and K.L. Goh Vascular function in Type 2 diabetes mellitus and pre-diabetes: the case for intrinsic endotheiopathy Diabet Med 16 1999 710 715
33. T. Nishikawa, D. Edelstein, and X.L. Du Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790
34. F. Garcia Soriano, L. Virag, and P. Jagtap Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation Nat Med 7 2001 108 113
35. E. O'Riordan, N. Mendelev, and S. Patschan Chronic NOS inhibition actuates endothelial-mesenchymal transformation Am J Physiol Heart Circ Physiol 292 2007 H285 H294
36. J. Li, X. Qu, and J.F. Bertram Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice Am J Pathol 175 2009 1380 1388